Margot Lindsay

Counsel, London



Margot is counsel in the London Corporate/M&A practice. She advises listed companies, private companies, financial sponsors and international corporates on international and domestic public and private M&A, joint ventures, reorganisations and general corporate advisory matters.

Margot has broad experience across a range of industries, with a particular focus on healthcare, consumer products and infrastructure.

Prior to joining White & Case, Margot worked for one of the UK’s magic circle law firms for 8 years and also worked for a top tier law firm in New Zealand.

Bars and Courts
England and Wales
University of Otago

New Zealand

University of Otago

New Zealand



MOL Group on its announced US$1.57 billion deal with Chevron to acquire a 9.57 percent stake in the Azeri-Chirag-Gunashli (ACG) oil field in the Caspian Sea off Azerbaijan and an effective 8.90 percent interest in the Baku-Tbilisi-Ceyhan (BTC) pipeline.

Avon Rubber plc on its announced agreement to acquire 3M's ballistic-protection business in the US. Avon is a UK-listed innovative technology group, specialising in chemical, biological, radiological and nuclear (CBRN) and respiratory protection systems.

Allianz Capital Partners on its co-investment in GasNet, the Czech Republic's largest gas distribution network business, as part of a consortium of investors led by Macquarie Infrastructure and Real Assets.

J Sainsbury plc on its proposed £15 billion merger with Asda.*

Reckitt Benckiser Group plc on the US$17.9 billion acquisition of Mead Johnson Nutrition Company.*

UBM plc on its takeover by Informa plc for £3.8 billion.*

Macquarie on the acquisition of a 50 percent interest in the Race Bank Offshore Wind Farm from Ørsted for £1.6 billion.*

Anglo American on the US$1.7 billion sale of its niobium and phosphates divisions to China Molybdenum.*

Novartis on its asset swap with GSK, where Novartis sold its vaccines business to GSK for US$7.1 billion, Novartis acquired GSK's oncology business for US$16 billion and the parties entered into a joint venture in respect of the parties' consumer health businesses.*

Takeda Pharmaceuticals on the US$578 million sale of its core respiratory product portfolio to AstraZeneca.*

UniCredit Group on its aborted £5.45 billion global asset management joint venture with Banco Santander, Warburg Pincus and General Atlantic.*

*Matters worked on prior to joining White & Case.